Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CELON PHARMA Aktie jetzt für 0€ handeln | |||||
09.04. | Celon Pharma to receive nearly PLN 66 mln from EU funds competition | 1 | PAP | ||
05.03. | Celon's PDE10A inhibitor reduces involuntary movements in midstage Parkinson's trial | 2 | FierceBiotech | ||
27.06.24 | Dividendenbekanntmachungen (27.06.2024) | 12.175 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVENTURE INC JP3122380003 22 JPY 0,128 EUR AGC INC JP3112000009 105 JPY 0,6111 EUR ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVARTIS | 103,32 | +0,51 % | Märkte am Morgen: Lanxess, Öl, Roche, Novartis, Rheinmetall, Hensoldt, Renk | Der Mai gilt eigentlich als schlechter Börsenmonat. In diesem Jahr wurde er seinem Ruf allerdings nicht gerecht. Der DAX legte im Mai 6,7 Prozent zu, mehrere Allzeithochs inklusive. Heute dürfte der... ► Artikel lesen | |
GILEAD SCIENCES | 97,76 | +1,22 % | Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of "The Centrifuge Sessions" | NORTHAMPTON, MA / ACCESS Newswire / June 5, 2025 / At Gilead, we're advancing new ways to help end the HIV epidemic by delivering innovative therapies to those who need them most. In our latest episode... ► Artikel lesen | |
AURORA CANNABIS | 4,910 | +3,92 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
GSK | 17,985 | -0,39 % | BERENBERG stuft GSK auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat GSK nach gutem Lauf bei unverändertem Kursziel von 1600 Pence von "Buy" auf "Hold" abgestuft. Die Kursentwicklung des Pharmakonzerns sei in... ► Artikel lesen | |
TILRAY BRANDS | 0,348 | +2,08 % | Tilray Unveils Bold Summer Craft Beer Lineup Across Iconic Breweries | ||
WPD PHARMACEUTICALS | 0,002 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
SINOPHARM | 2,110 | +1,78 % | Kurs der Sinopharm Group fällt ab (2,054 €) | Am Aktienmarkt notiert der Anteilsschein der Sinopharm Group aktuell ein wenig leichter. Die Aktie notiert derzeit bei 2,05 Euro. Für Inhaber der Sinopharm Group ist der heutige Handelstag bisher nicht... ► Artikel lesen | |
BETTER PLANT SCIENCES | 0,010 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
BACHEM | 57,10 | +0,44 % | Bachem Holding AG: Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg | Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded... ► Artikel lesen | |
UNITED THERAPEUTICS | 282,00 | +0,82 % | Leerink Partners maintains positive outlook on United Therapeutics stock | ||
CATALENT | 59,93 | 0,00 % | Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors | Expert appointment further accelerates Prolific's ability to deliver impactful protein production solutions as it prepares to expand its light-controlled bioproduction offerings
Prolific Machines... ► Artikel lesen | |
INMED PHARMACEUTICALS | 2,680 | -4,29 % | InMed Pharmaceuticals: InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update | Vancouver, British Columbia--(Newsfile Corp. - May 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary... ► Artikel lesen | |
OTSUKA HOLDINGS | 45,000 | +7,14 % | Otsuka's kidney disease drug halves UPCR levels in phase 3 study | ||
HUTCHMED | 2,500 | -1,57 % | HUTCHMED's NDA For Fruquintinib-sintilimab Combo In Renal Cancer Accepted By China's NMPA | BEIJING (dpa-AFX) - HUTCHMED (China) Limited (HCM) and Innovent Biologics, Inc. announced that the New Drug Application (NDA) for the combination of fruquintinib and sintilimab for the treatment... ► Artikel lesen | |
MEDICURE | 0,660 | -8,33 % | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results | WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen |